Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2014

Goodwill And Intangible Assets Disclosure [Abstract]

6.	Goodwill and Intangible Assets


(Table only in thousands)	Six months ended June 30, 2014						Year ended December 31, 2013
Goodwill / Tradename	Goodwill			Tradename			Goodwill		Tradename
Beginning balance	$	132,220		$	18,419		$	19,548	$	3,526
Acquisitions and related adjustments		1,841			—			112,306		14,775
Foreign currency adjustments		(60	)		(25	)		366		118

	$	134,001		$	18,394		$	132,220	$	18,419


	As of June 30, 2014				As of December 31, 2013
(Table only in thousands) Intangible assets – finite life	Cost		Accum. Amort.		Cost		Accum. Amort.
Patents	$	1,429	$	1,408	$	1,423	$	1,383
Employment agreements		757		345		762		221
Technology		8,897		1,769		8,942		789
Customer lists		41,357		5,985		41,582		3,503

	$	52,440	$	9,507	$	52,709	$	5,896

Activity for the six months ended June 30, 2014 and 2013 is as follows:


(Table only in thousands)	2014			2013
Intangible assets – finite life, net at beginning of period	$	46,813		$	1,283
Amortization expense		(3,593	)		(750	)
Acquisitions/purchase accounting adjustments		(175	)		13,477
Foreign currency adjustments		(112	)		(26	)

Intangible assets – finite life, net at end of period	$	42,933		$	13,984

Amortization expense of finite life intangible assets was $1.8 million and $0.6 million for the three-months periods ended June 30, 2014 and 2013, respectively, and $3.6 million and $0.8 million for the six-month periods ended June 30, 2014 and 2013, respectively. Amortization over the next five years for finite life intangibles is expected to be $3.4 million for the remainder of 2014, $7.1 million in 2015, $6.1 million in 2016, $5.2 million in 2017, and $4.0 million in 2018.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details